On Wednesday, pharmaceutical giant Merck made a historic announcement: it would widely share its Covid-19 therapy drug patents royalty-free to enable mass production for the poorest countries in the world. Jewish investors helped them get there. A month ago, JLens staff met with six of Merck’s senior Corporate Social Responsibility executives to advocate directly with the company to share its technology and increase its transparency around drug pricing. JLens, the Jewish comm